Fig. 3: LOX-1 expression pattern in breast cancer cells and tissues.
From: Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
Immunostaining a–c and RNA b–d analysis of LOX-1 isoforms pattern expression in different breast tissues a, b (**p < 0.005) and cell lines phenotypes c, d (**p < 0.005; ****p < 0.00005). qRT-PCR analysis shows that LOX-1 and its LOX-1Δ4 isoform are both expressed in breast cancer cells analyzed but at different levels depending on the cell line phenotype. Values are mean ± SD, and n = 3
